TransEnterix to Present at the 37th Annual J. P. Morgan Healthcare Conference
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Dec 20, 2018--TransEnterix, Inc. (NYSE American:TRXC) announced today that Todd M. Pope, President and Chief Executive Officer, and Joseph P. Slattery, Executive Vice President and Chief Financial Officer, will present at the 37th Annual J.P. Morgan Healthcare Conference at The Westin St. Francis Hotel in San Francisco, California. The presentation is scheduled to take place at 12:00 pm Pacific Time (3:00 pm Eastern Time), Monday, January 7, 2019.
A live audio webcast of the conference presentation will be available online at the investor relations page of the Company’s website at http://ir.transenterix.com/events.cfm. A replay of the webcast will be archived on the website for approximately 90 days.
TransEnterix is a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery by addressing the clinical and economic challenges associated with current laparoscopic and robotic options in today’s value-based healthcare environment. The Company is focused on the commercialization of the Senhance Surgical System, which digitizes laparoscopic minimally invasive surgery. The system allows for robotic precision, haptic feedback, surgeon camera control via eye sensing and improved ergonomics while offering responsible economics. The Senhance Surgical System is available for sale in the US, the EU and select other countries. For more information, visit www.transenterix.com.
View source version on businesswire.com:https://www.businesswire.com/news/home/20181220005184/en/
CONTACT: TransEnterix, Inc.
Mark Klausner, 443-213-0501
Joanna Rice, 951-751-1858
KEYWORD: CALIFORNIA NORTH CAROLINA UNITED STATES NORTH AMERICA
INDUSTRY KEYWORD: BIOTECHNOLOGY GENERAL HEALTH MEDICAL DEVICES HEALTH
SOURCE: TransEnterix, Inc.
Copyright Business Wire 2018.
PUB: 12/20/2018 12:06 AM/DISC: 12/20/2018 06:55 AM